AXA S.A. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AXA S.A. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$748,132
-83.2%
771,000
-83.0%
0.00%
-80.0%
Q2 2023$4,455,753
-4.0%
4,530,0000.0%0.02%
-6.2%
Q1 2023$4,643,069
-4.1%
4,530,0000.0%0.02%
-5.9%
Q4 2022$4,841,438
-67.2%
4,530,000
-69.5%
0.02%
-41.4%
Q3 2022$14,746,161
+0.3%
14,860,0000.0%0.03%
+7.4%
Q2 2022$14,707,917
-13.2%
14,860,000
-11.9%
0.03%
+12.5%
Q1 2022$16,935,851
+90.2%
16,860,000
+100.0%
0.02%
+4.3%
Q4 2021$8,906,000
-19.0%
8,430,000
-20.4%
0.02%
-25.8%
Q3 2021$10,997,000
-50.3%
10,590,000
-50.0%
0.03%
-3.1%
Q2 2021$22,132,000
+99.2%
21,180,000
+100.0%
0.03%
-5.9%
Q1 2021$11,110,000
-2.1%
10,590,0000.0%0.03%
-5.6%
Q4 2020$11,354,000
+28.0%
10,590,000
+27.3%
0.04%
+12.5%
Q3 2020$8,867,000
+21.7%
8,320,000
+39.6%
0.03%
+128.6%
Q2 2020$7,284,0005,960,0000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2022
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 16,732,000$16,408,3851.23%
SONA ASSET MANAGEMENT (US) LLC 23,125,000$22,451,9230.93%
SSI INVESTMENT MANAGEMENT LLC 8,726,000$8,464,2200.69%
PFM Health Sciences, LP 15,000,000$14,587,5000.69%
RWC Asset Management LLP 10,000,000$9,709,0000.63%
Sonora Investment Management Group, LLC 6,245,000$6,108,1820.52%
Paloma Partners Management Co 10,006,000$9,733,2850.34%
MACKAY SHIELDS LLC 9,891,000$9,594,2700.26%
PALISADE CAPITAL MANAGEMENT, LP 8,704,000$8,455,0660.24%
Centiva Capital, LP 10,000,000$9,716,2880.21%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders